Status:
COMPLETED
Co-administration Study in Patients With Elevated Cholesterol and Coronary Heart Disease (0653-803)
Lead Sponsor:
Organon and Co
Conditions:
Hypercholesterolemia
Coronary Disease
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
The purpose of this study is to investigate additional cholesterol lowering effects in patients with coronary heart disease by giving an investigational drug with a patient's current approved choleste...
Detailed Description
The duration of treatment is 10 weeks.
Eligibility Criteria
Inclusion
- Patients with elevated cholesterol and coronary heart disease
Exclusion
- Patients who have cholesterol levels within normal ranges as identified by the study
Key Trial Info
Start Date :
March 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2004
Estimated Enrollment :
442 Patients enrolled
Trial Details
Trial ID
NCT00092625
Start Date
March 1 2003
End Date
August 1 2004
Last Update
August 15 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.